Robert Alexander
Hoofd Techniek/Wetenschap/O&O bij Reunion Neuroscience, Inc.
Vermogen: - $ op 31-07-2023
Profiel
Robert Alexander is currently the Chief Medical Officer at Reunion Neuroscience, Inc. Prior to his current position, he obtained a doctorate degree from Pritzker School of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
Reunion Neuroscience, Inc.
 Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada. -.--% | 12-06-2023 | 0 ( -.--% ) | - $ | 31-07-2023 |
Actieve functies van Robert Alexander
| Bedrijven | Functie | Begin |
|---|---|---|
Reunion Neuroscience, Inc.
Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada. | Hoofd Techniek/Wetenschap/O&O | 18-01-2023 |
Opleiding van Robert Alexander
| Pritzker School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
 | Health Technology |
